We also expect the methodology to be extended to the investigation of aggregation processes associated with other misfolded peptides implicated in various pathologies, including tau in Alzheimer’s disease and α-syncuclein in Parkinson’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.